NASDAQ · Medical - Specialties
ChronoScale Holdings Corporation (CHRN) Stock
$18.59
-2.31%
NASDAQ: CHRN
Healthcare
Valuation
Financials & Margins
Annual Financials (USD)
Balance Sheet (USD)
Latest News
Adeia Picks a Fight, and Investors Pick the Exit
Trefis · Jul 3, 2026
ChronoScale (CHRN) Stock Valuation After Sharp 1 Year Surge And Rich P/S Multiple
Simply Wall St. · Jun 13, 2026
Top Midday Gainers
MT Newswires · Jun 4, 2026
ChronoScale Appoints Raj Jegannathan as Chief Technology Officer and Lawrence Lam as Chief Product Officer to Accelerate Global AI Infrastructure Strategy
GlobeNewswire · Jun 4, 2026
Cash Flow (USD)
Valuation & Return Ratios
Ownership
Insiders Held97.57%
Institutions Held1.19%
Institutions Float Held48.83%
Peer Comparison
About ChronoScale Holdings Corporation
ChronoScale Holdings Corporation is led by CEO Scott G. Davis, employs 55 people, headquartered in US, publicly traded since 2026.
ChronoScale Holdings Corporation (CHRN) stock trades at $18.59 with a market capitalization of $66.24M. The stock is valued at a price-to-earnings (P/E) ratio of -3.90, price-to-book of 0.69, price-to-sales of 32.48. Over the past 52 weeks the stock has ranged between $3.50 and $30.00, and currently trades 38.0% below its 52-week high.
On profitability, ChronoScale Holdings Corporation generates a return on equity (ROE) of -133.33%, return on capital employed of -118.18%, an operating margin of -100.00%, a net profit margin of -86.20%.